ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $73.4M

      Shares

      411k

      % of Portfolio

      0.64%

      Average Buy Price

      $141

      Avg closing price
      Price range

      40 Charles Brandes Johnson & Johnson Trades

      Charles Brandes's position in Johnson & Johnson is currently worth $73.4M. That's 0.64% of their equity portfolio (54th largest holding). The first Johnson & Johnson trade was made in Q3 2015. Since then Charles Brandes bought shares 25 more times and sold shares on fourteen occasions. The stake costed the investor $58M, netting the investor a gain of 27% so far.

      Avg closing price
      Price range
      Increased shares by 2.1% (+8.5k shares) Q2 2025
      Avg closing price $153.72
      Price range $146.36 - $159.82
      Increased shares by 1.3% (+5.33k shares) Q1 2025
      Avg closing price $156.08
      Price range $142.09 - $167.70
      Increased shares by 16.3% (+55.6k shares) Q4 2024
      Avg closing price $154.69
      Price range $143.31 - $165.86
      Increased shares by 5.2% (+16.8k shares) Q3 2024
      Avg closing price $159.22
      Price range $145.48 - $167.38
      Increased shares by 17.1% (+47.3k shares) Q2 2024
      Avg closing price $148.72
      Price range $144.38 - $157.78
      Increased shares by 3.3% (+8.76k shares) Q1 2024
      Avg closing price $159.17
      Price range $155.22 - $162.74
      Increased shares by 25.5% (+54.6k shares) Q4 2023
      Avg closing price $153.34
      Price range $145.60 - $158.88
      Increased shares by 24.7% (+42.3k shares) Q3 2023
      Avg closing price $165.01
      Price range $155.75 - $174.48
      Increased shares by 5.1% (+8.39k shares) Q2 2023
      Avg closing price $161.40
      Price range $154.35 - $166.11
      Increased shares by 25.5% (+33.2k shares) Q1 2023
      Avg closing price $161.47
      Price range $151.05 - $180.25
      Sold 14.8% shares (-22.7k shares) Q4 2022
      Avg closing price $172.66
      Price range $160.20 - $179.76
      Increased shares by 4.7% (+6.82k shares) Q3 2022
      Avg closing price $169.22
      Price range $161.33 - $179.52
      Increased shares by 9.0% (+12.1k shares) Q2 2022
      Avg closing price $178.17
      Price range $168.19 - $186.01
      Increased shares by 12.6% (+14.9k shares) Q1 2022
      Avg closing price $170.15
      Price range $158.14 - $179.59
      Increased shares by 1.1% (+1.33k shares) Q4 2021
      Avg closing price $163.71
      Price range $155.93 - $173.01
      Increased shares by 10.5% (+11.2k shares) Q3 2021
      Avg closing price $170.61
      Price range $161.50 - $179.47
      Increased shares by 56.7% (+38.4k shares) Q2 2021
      Avg closing price $165.55
      Price range $159.48 - $171.07
      Increased shares by 11.0% (+6.73k shares) Q1 2021
      Avg closing price $161.81
      Price range $153.07 - $170.48
      Increased shares by 12.1% (+6.59k shares) Q4 2020
      Avg closing price $147.57
      Price range $137.11 - $157.38
      Sold 18.5% shares (-12.3k shares) Q3 2020
      Avg closing price $147.97
      Price range $140.38 - $153.83

      News about Johnson & Johnson and Charles Brandes

      At 12.6% CAGR, Global Vaccines Market Size to Hit USD 153.49 Bn in 2028, Says Brandessence Market Research

      At 12.6% CAGR, Global Vaccines Market Size to Hit USD 153.49 Bn in 2028, Says Brandessence Market Research

      Kwhen Finance Kwhen Finance, over 3 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×